Report Code : A01352
growth of the global proteomics market is driven by increased utility of proteomics in the diagnosis of diseases and identification of potential new drugs for the treatment of various diseases. Factors such as rise in focus of key players toward product development, surge in R&D expenditure on proteomics, increase in popularity for personalized medicines, and technological advancements in proteomics are expected to drive the proteomics market.
Onkar Sumant
Manager, Healthcare at Allied Market Research
According to a new report published by Allied Market Research, titled, “Proteomics Market by Component and Application: Opportunity Analysis and Industry Forecast, 2019-2027,” the global proteomics market was valued at $21.12 billion in 2019, and is projected to reach $49.97 billion by 2027 at a CAGR of 12.2% from 2020 to 2027. Proteomics has the capacity to explain questions that were unsolved by genomics, as proteins are the functional unit of cells. Advancements in technologies such as mass spectrometry and chromatography and development of computer algorithms for database searching facilitate proteomics research. The analysis of target proteins for disease diagnosis is the largest application of proteomics.
Most markets are dropping down as COVID-19 outbreak has negatively affected various healthcare related markets. The development of therapeutic and preventive strategies requires an accurate understanding of the role that proteins play in the SARS-CoV-2 infection process and progression of COVID-19. A wide array of identification and separation techniques can isolate proteins from complex mixtures, facilitating the analysis of protein-protein interactions, temporal expression patterns and cellular or subcellular distribution. For instance, most common separation methods are one- and two-dimensional gel electrophoresis and high-performance liquid chromatography, whereas mass spectrometry (MS) forms the backbone of protein detection and identification. MS-based detection can provide simple and rapid detection of SARS-CoV-2, even among recovered patients. Hence, in the perspective of COVID-19, proteomics can help to reveal novel biomarkers and define point-of-care procedures that could mean cost-effective healthcare can be delivered closer to the patient.
The key drivers of the proteomics market include increased in popularity of personalized medicines, surge in R&D expenditure and technological advancements associated with proteomics components. Moreover, high costs associated with proteomics components and dearth of skilled professionals hamper the market growth. Conversely lucrative opportunities associated with biomarker identification and developments in mass spectrometry-based proteomics are expected to provide lucrative proteomics market growth opportunities.
The protein microarray segment generated the highest revenue in 2019 in the proteomics instruments market, owing to high usage of this technology to track protein interactions in lesser time as compared to other technologies. Moreover, this method is labor-intensive and cost-effective. With the help of protein array, the comprehensive information about the DNA/RNA binding proteins can be made available.
By reagents segment, immunoassays held the highest proteomics market share in the total market, as they are extensively utilized in primary screening in drug discovery and microarray technologies. On the basis of application, the drug discovery segment accounted for the majority market share in 2019, owing to increase in awareness of personalized medicines in both emerging and developed markets, thereby boosting the proteomics market growth in coming years.
North America held the largest proteomics market share of nearly 39.0% of the total market in 2019, due to increase in popularity and adoption of personalized medicines and favorable government funding & initiatives to develop novel therapeutics. However, Asia-Pacific is expected to grow at a CAGR of 15.6% from 2019 to 2027, owing to rise in prevalence of chronic diseases and increase in interest of researchers to utilize proteomics in disease diagnosis & treatment.
The global proteomics market is segmented on the basis of component, application, and region. On the basis of component, the market is categorized into reagents, instruments, and services. The reagents segment is further classified into microarray, spectrometry, X-ray crystallography, chromatography, electrophoresis, immunoassay, and protein fractionation reagents. Likewise, the proteomics instruments segment is sub segmented into protein microarray, spectrometry, chromatography, electrophoresis, surface plasmon resonance, X-ray crystallography, and protein fractionation systems. The spectrometry segment is subdivided into mass spectrometry and NMR spectrometry. Similarly, the chromatography segment is sub classified into HPLC systems, ion chromatography, affinity chromatography, and supercritical fluid chromatography. The applications covered in the study include drug discovery, disease diagnosis, and others. Region wise, the proteomics market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings Of The Study
The key companies profiled in the proteomics market report include Agilent Technologies Inc., Danaher Corporation, LI-COR, Inc., PerkinElmer, Inc., Thermo Fisher Scientific, Inc., HORIBA, Ltd., Bio-Rad Laboratories, Inc., Bruker Corporation, General Electric (GE), and Waters Corporation. The other players included in the value chain analysis (but not included in the report) are Becton, Dickinson and Company, Caprion Biosciences, and others.
Talk to David (Europe)
Talk to Sona Padman (Americas)
5933 NE Win Sivers Drive #205,
Portland, OR 97220 United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91 2066346060
Fax: +1(855) 550-5975
Tushar Nagose
Communications Officer
Allied Market Research
Contact Toll Free: +1-800-792-5285
Drop us an email at
media@alliedmarketresearch.com
Proteomics Market by Component (Instruments, Reagents, and Services) and Application (Drug Discovery, Disease Diagnosis, and Others): Global Opportunity Analysis and Industry Forecast, 2019-2027
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that matter to your business. Stay updated on the area that interests you.
Buy Full Version
"Proteomics Market"
Purchase Enquiry
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers